HNSCC is the sixth most common human cancer globally. In Saudi Arabia, HNSCC accounts for seven percent of all newly diagnosed cancer cases. The PIK3CA is one of the most commonly mutated oncogene in human malignancies, including HNSCC.
OBJECTIVE:
The objective of this study is to identify mutations in exon 9 and exon 20 of the PIK3CA gene among Saudi HNSCC patients, determine the frequency of these mutations and correlate with clinical and pathological findings.
METHODS:
Histopathologically confirmed paraffin embedded HNSCC tumor tissues from 48 patients were obtained. Capillary sequencing method was used to sequence exons 9 and 20 of the PIK3CA gene. Concurrently, the expression analysis of the PIK3CA and PTEN genes were performed using real-time PCR.
RESULTS:
Sixty percent of the samples studied were of pharyngeal cancer. A total of seven mutations were identified in exons 9 and 20 of the PIK3CA gene in 14 HNSCC tumor tissue specimens. The seven mutations encompassed one hot spot mutation E542K, a common mutation T1025T and the five novel mutation comprising three missense and two silent mutations. Interestingly, eight out of the 14 samples with a mutation were of patients with pharyngeal cancer.
CONCLUSION:
PIK3CA gene plays a crucial role in carcinogenesis in general and HNSCC in particular. The identification of five novel mutations suggest that Saudis may have different frequencies of somatic genetic alterations that may influence HNSCC compared to other populations.
Di CristofanoA, PandolfiP.P, The multiple roles of PTEN in tumor suppression, Cell, 100 (2000), 387-90.
2.
SuetaA, YamamotoY, Yamamoto-IbusukiM, HayashiM, TakeshitaT, et al. An Integrative Analysis of PIK3CA Mutation, PTEN, and INPP4B Expression in Terms of Trastuzumab Efficacy in HER2-Positive Breast Cancer, PLoS ONE, 9 (2014), e116054.
3.
ChaturvediA.K, EngelsE.A, AndersonW.F, GillisonM.L, Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States, J Clin Oncol, 26 (2008), 612-9.
4.
MuruganA.K, HongN.T, FukuiY, MunirajanA.K, TsuchidaN, Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas, Int J Oncol, 32 (2008), 101-11.
5.
LlewellynC.D, LinklaterK, BellJ, JohnsonN.W, WarnakulasuriyaK.A, Squamous cell carcinoma of the oral cavity in patients aged 45 years and under: A descriptive analysis of 116 cases diagnosed in the South East of England from 1990 to 1997, Oral Oncol, 39 (2003), 106-14.
6.
LeemansC.R, BraakhuisB.J, BrakenhoffR.H, The molecular biology of head and neck cancer, Nat Rev Cancer, 11 (2011), 9-22.
7.
LevineD.A, BogomolniyF, YeeC.J, LashA, BarakatR.R, et al. Frequent mutation of the PIK3CA gene in ovarian and breast cancers, Clin Cancer Res, 11 (2005), 2875-2878.
8.
BroderickD.K, DiC, ParrettT.J, SamuelsY.R, CumminsJ.M, et al. Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas, Cancer Res, 64 (2004), 5048-5050.
9.
HayesD.N, GrandisJ.R, El-NaggarA.K, Comprehensive genomic characterization of squamous cell carcinoma of the head and neck in the Cancer Genome Atlas, American Association for Cancer Research Annual Meeting, Washington, DC, (2013), 1117.
10.
AkagiI, MiyashitaM, MakinoH, NomuraT, HagiwaraN, TakahashiK, et al. Overexpression of PIK3CA is associated with lymph node metastasis in esophageal squamous cell carcinoma, Int J Oncol, 34 (2009), 767-75.
11.
EngelmanJ.A, LuoJ, CantleyL.C, The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism, Nat Rev Genet, 7 (2006), 606-19.
12.
EngelmanJ.A, Targeting PI3K signalling in cancer: Opportunities, challenges and limitations, Nat Rev Cancer, 9 (2009), 550-62.
13.
FriedmanJ.M, StavasM.J, CmelakA.J, Clinical and scientific impact of human papillomavirus on head and neck cancer, World Journal of Clinical Oncology, 5(4) (2014), 781-791.
14.
LeeJ.W, SoungY.H, KimS.Y, LeeH.W, ParkW.S, et al. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas, Oncogene, 24 (2004), 1477-1480.
15.
KozakiK, ImotoI, PimkhaokhamA, HasegawaS, TsudaH, OmuraK, et al. PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma, Cancer Sci, 97 (2006), 1351-8.
16.
BachmanK.E, ArganiP, SamuelsY, SillimanN, PtakJ, et al. The PIK3CA gene is mutated with high frequency in human breast cancers, Cancer Biol Ther, 3 (2004), 772-775.
17.
MorrisL.G, TaylorB.S, BivonaT.G, GongY, EngS, BrennanC.W, et al. Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers, Proc Natl Acad Sci U S A, 108 (2011), 19024-9.
18.
AleskandaranyM.A, RakhaE.A, AhmedM.A, PoweD.G, PaishE.C, MacmillanR.D, et al. PIK3CA expression in invasive breast cancer: A biomarker of poor prognosis, Breast Cancer Res Treat, 122 (2010), 45-53.
19.
AgrawalN, FrederickM.J, PickeringC.R, BettegowdaC, ChangK, LiR.J, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1, Science, 333 (2011), 1154-7.
20.
StranskyN, EgloffA.M, TwardA.D, KosticA.D, CibulskisK, SivachenkoA, et al. The mutational landscape of head and neck squamous cell carcinoma, Science, 333 (2011), 1157-60.
21.
SiegelR, NaishadhamD and JemalA, Cancer statistics, CA Cancer J Clin, 62 (2012), 10-29.
22.
BlanchaertR.H, Oral and oral pharyngeal cancer: An update on incidence and epidemiology, identification, advances in treatment, and outcomes, Compend ContinEduc Dent, 23 (2002), 25-9.
23.
VelhoS, OliveiraC, FerreiraA, FerreiraA.C, SurianoG, et al. The prevalence of PIK3CA mutations in gastric and colon cancer, Eur J Cancer, 41 (2005), 1649-1654.
24.
ForbesS.A, TangG, BindalN, BamfordS, DawsonE, et al. COSMIC (the Catalogue of Somatic Mutations in Cancer): A resource to investigate acquired mutations in human cancer, Nucleic Acids Res, 38 (2008), D652-D657.
25.
GolasS.M, Trends in palatine tonsillar cancer incidence and mortality rates in the United States, Community Dent Oral Epidemiol, 35 (2007), 98-108.
26.
SudaT, HamaT, KondoS, YuzaY, YoshikawaM, UrashimaM, et al. Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma, BMC Cancer, 12 (2012), 416.
27.
YuanT.L, CantleyL.C, PI3K pathway alterations in cancer: Variations on a theme, Oncogene, 27 (2008), 5497-510.
28.
SeiwertT.Y, KeckM.K, ZuoZ, et al. Genomic profıling of a clinically annotated cohort of locoregionally advanced head and neck cancers (HNC) treated with defınitive chemoradiotherapy, J Clin Oncol, 30 (2012).
29.
LuiV.W, HedbergM.L, LiH, VangaraB.S, PendletonK, ZengY, et al. Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers, Cancer Discov, 3 (2013), 761-9.
30.
QiuW, SchönlebenF, LiX, HoD.J, CloseL.G, ManolidisS, et al. PIK3CA mutations in head and neck squamous cell carcinoma, Clin Cancer Res, 12 (2006), 1441-6.
31.
QiuW, TongG.X, ManolidisS, CloseL.G, AssaadA.M, SuG.H, Novel mutant-enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer, Int J Cancer, 122 (2008), 1189-94.
32.
CohenY, Goldenberg-CohenN, ShalmonB, ShaniT, OrenS, AmariglioN, et al. Mutational analysis of PTEN/ PIK3CA/AKT pathway in oral squamous cell carcinoma, Oral Oncol, 47(10) (2011), 946-50.
33.
HeY, Van't VeerL.J, Mikolajewska-HanclichI, Van VelthuysenM.L, ZeestratenE.C, NagtegaalI.D, et al. PIK3CA mutations predict local recurrences in rectal cancer patients, Clin Cancer Res, 15 (2009), 6956-62.
34.
SamuelsY, WangZ, BardelliA, SillimanN, PtakJ, SzaboS, et al. High frequency of mutations of the PIK3CA gene in human cancers, Science, 304 (2004), 554.
